Medicare Price Cuts on 10 Drugs, Biggest 79% Drop This Year
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Which Robo Advisor Outperformed In 2026 highlights top performers and the tactics behind their gains, plus notes on risk and diversification.
24,805 articlesMedicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
May home sales fell again, highlighting an ongoing affordability squeeze as mortgage costs remain elevated. The data ...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
After a two-week export-control standoff, Anthropic’s most powerful AI models are back online. The settlement restore...
Samsung Electronics and several Korean firms pushed back on Open USD participation claims, saying they had no formal ...
At age 65, Health Savings Accounts shift from a pure medical fund to a hybrid tool that can rival a 401(k) for non-me...
In 2026, property owners are selling experiences, not just space. Lenders are adjusting terms as tenants sign leases ...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
ONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...